Corcept Therapeutics Inc (CORT)
22.48
-0.52
(-2.26%)
USD |
NASDAQ |
Apr 24, 16:00
22.50
+0.02
(+0.11%)
After-Hours: 20:00
Corcept Therapeutics Total Assets (Quarterly): 621.52M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 621.52M |
| September 30, 2023 | 594.02M |
| June 30, 2023 | 524.62M |
| March 31, 2023 | 617.85M |
| December 31, 2022 | 583.43M |
| September 30, 2022 | 533.26M |
| June 30, 2022 | 496.36M |
| March 31, 2022 | 468.12M |
| December 31, 2021 | 423.76M |
| September 30, 2021 | 585.40M |
| June 30, 2021 | 568.48M |
| March 31, 2021 | 552.40M |
| December 31, 2020 | 571.73M |
| September 30, 2020 | 534.12M |
| June 30, 2020 | 497.82M |
| March 31, 2020 | 445.49M |
| December 31, 2019 | 412.31M |
| September 30, 2019 | 367.02M |
| June 30, 2019 | 328.68M |
| March 31, 2019 | 320.21M |
| December 31, 2018 | 311.69M |
| September 30, 2018 | 299.75M |
| June 30, 2018 | 274.38M |
| March 31, 2018 | 242.98M |
| December 31, 2017 | 220.54M |
| Date | Value |
|---|---|
| September 30, 2017 | 110.67M |
| June 30, 2017 | 86.54M |
| March 31, 2017 | 75.34M |
| December 31, 2016 | 68.75M |
| September 30, 2016 | 62.93M |
| June 30, 2016 | 56.84M |
| March 31, 2016 | 52.91M |
| December 31, 2015 | 51.90M |
| September 30, 2015 | 48.38M |
| June 30, 2015 | 48.36M |
| March 31, 2015 | 48.22M |
| December 31, 2014 | 34.63M |
| September 30, 2014 | 37.16M |
| June 30, 2014 | 44.39M |
| March 31, 2014 | 52.83M |
| December 31, 2013 | 63.08M |
| September 30, 2013 | 71.06M |
| June 30, 2013 | 79.69M |
| March 31, 2013 | 88.14M |
| December 31, 2012 | 99.17M |
| September 30, 2012 | 105.52M |
| June 30, 2012 | 38.62M |
| March 31, 2012 | 42.89M |
| December 31, 2011 | 39.83M |
| September 30, 2011 | 46.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
328.68M
Minimum
Jun 2019
621.52M
Maximum
Dec 2023
511.92M
Average
533.26M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical Inc | 1.491B |
| Alnylam Pharmaceuticals Inc | 3.830B |
| Catalyst Pharmaceuticals Inc | 470.11M |
| United Therapeutics Corp | 7.167B |
| XOMA Corp | 234.30M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 114.81M |
| Shareholders Equity (Quarterly) | 506.70M |
| Current Ratio | 4.389 |